BeOne Medicines AG - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US07725L1026

SecurityONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
InstitutionWalleye Capital LLC
Latest Disclosed Ownership21,051 shares
Latest Disclosed Value $ 6,251,515
Walleye Capital LLC ownership in ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)

On May 13, 2026 - Walleye Capital LLC filed a 13F-HR/A form disclosing ownership of 21,051 shares of BeOne Medicines AG - Depositary Receipt (Common Stock) (US:ONC) valued at $6,251,515 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 2,942 shares of BeOne Medicines AG - Depositary Receipt (Common Stock). This represents a change in shares of 615.53% during the quarter. The current value of the position is $5,873,229 USD.

Walleye Capital LLC has a history of taking positions in derivatives of the underlying security (ONC) in the form of stock options. The firm currently holds call options representing 100 of underlying shares valued at $29,697 USD and put options representing 300 of underlying shares valued at $89,091 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ONC / BeOne Medicines AG - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F/A-1 BEONE MEDICINES SPONSORED ADS 07725L102 21,051 18,109 615.53 6,252 600.00 0.0260
2026-05-08 2026-03-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 21,051 18,109 6,252 0.0260
2026-02-13 2025-12-31 13F BEONE MEDICINES SPONSORED ADS 07725L102 2,942 2,942 894 0.0027
2025-11-14 2025-09-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 0 -36,645 -100.00 0 -100.00
2025-08-13 2025-06-30 13F BEONE MEDICINES SPONSORED ADS 07725L102 36,645 -36,102 -49.63 8,871 -55.20 0.0345
2025-05-14 2025-03-31 13F BEIGENE SPONSORED ADS 07725L102 72,747 68,248 1,516.96 19,800 2,282.55 0.0894
2025-02-13 2024-12-31 13F BEIGENE SPONSORED ADR 07725L102 4,499 -22,222 -83.16 831 -86.15 0.0020
2024-11-14 2024-09-30 13F BEIGENE SPONSORED ADR 07725L102 26,721 11,624 77.00 5,999 178.63 0.0125
2024-08-14 2024-06-30 13F BEIGENE SPONSORED ADR 07725L102 15,097 13,624 924.92 2,154 836.09 0.0038
2024-05-15 2024-03-31 13F BEIGENE SPONSORED ADR 07725L102 1,473 1,473 230 0.0004
2024-02-14 2023-12-31 13F BEIGENE SPONSORED ADR 07725L102 0 -7,788 -100.00 0 -100.00
2023-11-21 2023-09-30 13F/A-1 BEIGENE SPONSORED ADR 07725L102 7,788 7,788 1,401 0.0036
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A BEONE MEDICINES SPONSORED ADS Call 100 0.00 30 -3.33 n/a n/a n/a
2026-05-08 2026-03-31 13F BEONE MEDICINES SPONSORED ADS Call 100 30 n/a n/a n/a
2026-02-13 2025-12-31 13F BEONE MEDICINES SPONSORED ADS Call 100 30 n/a n/a n/a
2024-11-14 2024-09-30 13F BEIGENE SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-14 2024-06-30 13F BEIGENE SPONSORED ADR Call 2,700 385 n/a n/a n/a
2024-05-15 2024-03-31 13F BEIGENE SPONSORED ADR Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F BEIGENE SPONSORED ADR Call 1,100 83.33 198 85.05 n/a n/a n/a
2023-11-21 2023-09-30 13F/A BEIGENE SPONSORED ADR Call 600 -81.82 108 -81.80 n/a n/a n/a
2023-08-14 2023-06-30 13F BEIGENE SPONSORED ADR Call 3,300 230.00 588 173.49 n/a n/a n/a
2023-05-15 2023-03-31 13F BEIGENE SPONSORED ADR Call 1,000 25.00 216 22.86 n/a n/a n/a
2023-02-14 2022-12-31 13F BEIGENE SPONSORED ADR Call 800 176 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-13 2026-03-31 13F/A BEONE MEDICINES SPONSORED ADS Put 300 89 n/a n/a n/a
2026-05-08 2026-03-31 13F BEONE MEDICINES SPONSORED ADS Put 300 89 n/a n/a n/a
2024-08-14 2024-06-30 13F BEIGENE SPONSORED ADR Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F BEIGENE SPONSORED ADR Put 400 100.00 63 72.22 n/a n/a n/a
2024-02-14 2023-12-31 13F BEIGENE SPONSORED ADR Put 200 -33.33 36 -32.08 n/a n/a n/a
2023-11-21 2023-09-30 13F/A BEIGENE SPONSORED ADR Put 300 -91.18 54 -91.25 n/a n/a n/a
2023-08-14 2023-06-30 13F BEIGENE SPONSORED ADR Put 3,400 3,300.00 606 2,785.71 n/a n/a n/a
2023-05-15 2023-03-31 13F BEIGENE SPONSORED ADR Put 100 -50.00 22 -51.16 n/a n/a n/a
2023-02-14 2022-12-31 13F BEIGENE SPONSORED ADR Put 200 44 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.